THE ARGENTINE CITIZENS DECLARATION.

P. Bard,C. Best,H. Davis,H. Essex,W. O. Fenn,W. F. Hamilton,M. Visscher

DOI: https://doi.org/10.1126/SCIENCE.99.2565.166

IF: 56.9

1944-02-25

Science

Abstract:

What problem does this paper attempt to address?

Selective upregulation of a functional β7 integrin on differentiating eosinophils

Joachim Lundahl,R. Sehmi,L. Hayes,K. Howie,J. Denburg

DOI: https://doi.org/10.1034/j.1398-9995.2000.00574.x

2000-09-01

Abstract:Background: The sequence of adhesion‐molecule expression during eosinophil differentiation remains unclear.
[Hypertrophy of the ileocecal valve. Malabsorption syndrome].

A. Salama,J. Albina

1969-04-25

Abstract:
Newborn Screening for Ornithine Transcarbamylase Deficiency in Zhejiang Province and the Follow-Up Analysis

周朵,杨茹莱,黄新文,童凡,黄晓磊,钱古柃,杨昕,杨建滨,赵正言

DOI: https://doi.org/10.3760/cma.j.cn101070-20221102-01246

2023-01-01

Abstract:Objective:To investigate the incidence, clinical characteristics and prognosis of ornithine transcarbamylase deficiency(OCTD) in newborns in Zhejiang Province.Methods:A retrospective research was conducted.A total of 4 261 036 newborns from Department of Genetics and Metabolism, Children′s Hospital, Zhejiang University School of Medicine, between January 2009 and December 2021 were screened for inherited metabolic disorders using tandem mass spectrometry.OCTD was confirmed by urine organic acid and OTC gene analysis.Patients with OTCD received guidance on diet and lifestyle management, and were treated with citrulline and arginine.Long-term follow-up was performed.Their growth and intellectual development were evaluated. Results:A total of 7 patients with OCTD were diagnosed, with an incidence of 1.6/1 million.All patients were males.Two patients had neonatal-onset OCTD, and the other 5 had late-onset OCTD.Symptoms occurred several times in 6 patients, inducing hyperammonemia and hepatic impairment.One patient had no clinical manifestation.One patient died in the neonatal period.Blood citrulline levels were decreased in 7 patients to varying degrees.Uracil levels were increased in 4 patients, and 1 of them was complicated with elevated orotic acid levels.All patients had hemizygote variations in the OTC gene, including 6 missense variations(c.604C>T, c.386G>A, c.779T>C, c.1019C>T, c.594C>G, c.931G>A) and 1 intron variation(c.514-35C>G). Two variants(c.594C>G, c.514-35C>G) were never reported previously. Conclusions:The OTCD incidence by newborn screening is low with 1.6/1 million in Zhejiang province.All patients are males and present hypocitrullinemia.The clinical manifestations of OTCD are highly heterogeneous.The neonatal-onset form is severe and survivors always suffer serious sequelae.The late-onset form is mostly manifested with hyperammonemia and hepatic impairment.There may be association between phenotype and genotype.Two novel OTC variants are identified, which further expands the mutational spectrum.
Variant analysis and PGT-M of OTC gene in a Chinese family with ornithine carbamoyltransferase deficiency

Yao Zhou,Xinxing Jiang,Yongfang Zhang,Yu Zhang,Fei Sun,Yanlin Ma

DOI: https://doi.org/10.1186/s12884-024-06696-5

2024-07-22

Abstract:Background: Ornithine carbamoyltransferase deficiency (OTCD) is a kind of X-linked metabolic disease caused by a deficiency in ornithine transcarbamylase leading to urea cycle disorders. The main reason is that the OTC gene variants lead to the loss or decrease of OTC enzyme function, which hinders the ammonia conversion to urea, resulting in hyperammonemia and severe neurological dysfunction. Here, we studied one Chinese family of three generations who consecutively gave birth to two babies with OTCD. This study aims to explore the pathogenicity of two missense variants in the OTC gene and investigate the application of preimplantation genetic testing for monogenic (PGT-M) for a family troubled by Ornithine carbamoyltransferase deficiency (OTCD). Methods: The retrospective method was used to classify the pathogenicity of two missense variants in the OTC gene in a family tortured by OTCD. Sanger sequencing was used to validate the variants in the OTC gene, and then the pathogenicity of variants was confirmed through family analysis and bioinformatics software. We used PGT-M to target the OTC gene and select a suitable embryo for transplantation. Prenatal diagnosis was recommended to confirm previous results using Sanger sequencing and karyotyping at an appropriate gestational stage. Tandem mass spectrometry (MS-MS) and gas chromatography-mass spectrometry (GC-MS) were used to detect fetal metabolism after birth. The number of the study cohort is ChiCTR2100053616. Results: Two missense variants, c.959G > C (p.Arg320Pro) and c.634G > A (p.Gly212Arg), were validated in the OTC gene in this family. According to the ACMG genetic variation classification criteria, the missense variant c.959G > C can be considered as "pathogenic", and the missense variant c.634G > A can be regarded as "likely benign." PGT-M identified a female embryo carrying the heterozygous variant c.959G > C (p.Arg320Pro), which was selected for transplantation. Prenatal diagnosis revealed the same variant in the fetus, and continued pregnancy was recommended. A female baby was born, and her blood amino acid testing and urine organic acid testing were regular. Follow-up was conducted after six months and indicated the girl was healthy. Conclusion: Our research first validated the segregation of both c.959G > C and c.634G > A variants in the OTC gene in a Chinese OTCD family. Then, we classified variant c.959G > C as "pathogenic" and variant c.634G > A as "likely benign", providing corresponding theoretical support for genetic counseling and fertility guidance in this family. PGT-M and prenatal diagnosis were recommended to help the couple receive a female baby successfully with a six-month follow-up.
Tubular epithelial reflux in the kidney in aflatoxin poisoning.

T. Madhavan,K. Rao

DOI: https://doi.org/10.1002/PATH.1700930131

The Journal of Pathology and Bacteriology

Abstract:
A yeast-based complementation assay elucidates the functional impact of 200 missense variants in human PSAT1

Amy Sirr,Russell S Lo,Gareth A Cromie,Adrian C Scott,Julee Ashmead,Mirutse Heyesus,Aimée M Dudley

DOI: https://doi.org/10.1002/jimd.12227

Abstract:Defects in serine biosynthesis resulting from loss of function mutations in PHGDH, PSAT1, and PSPH cause a set of rare, autosomal recessive diseases known as Neu-Laxova syndrome (NLS) or serine-deficiency disorders. The diseases present with a broad range of phenotypes including lethality, severe neurological manifestations, seizures, and intellectual disability. However, because L-serine supplementation, especially if started prenatally, can ameliorate and in some cases even prevent symptoms, knowledge of pathogenic variants is medically actionable. Here, we describe a functional assay that leverages the evolutionary conservation of an enzyme in the serine biosynthesis pathway, phosphoserine aminotransferase, and the ability of the human protein-coding sequence (PSAT1) to functionally replace its yeast ortholog (SER1). Results from our quantitative, yeast-based assay agree well with clinical annotations and expectations based on the disease literature. Using this assay, we have measured the functional impact of the 199 PSAT1 variants currently listed in ClinVar, gnomAD, and the literature. We anticipate that the assay could be used to comprehensively assess the functional impact of all SNP-accessible amino acid substitution mutations in PSAT1, a resource that could aid variant interpretation and identify potential NLS carriers.
Variable disease manifestations and metabolic management within a single family affected by ornithine transcarbamylase deficiency

Joshua Baker,Lauren Hitchins,Erika Vucko,Kirsten Havens,Karen Becker,Katherine Arduini

DOI: https://doi.org/10.1016/j.ymgmr.2022.100906

2022-07-30

Abstract:We report on a family with ornithine transcarbamylase (OTC) deficiency, an X-linked urea cycle disorder, with variable disease severity and tailored management strategies based on each family member's biochemical profile and clinical presentation. Our primary patient is a female monozygotic twin who presented to medical care at 10 months of age with acute liver failure, gastrointestinal symptoms, altered mental status, hypoglycemia, and hyperammonemia. The patient's older brother, known to have hemizygous OTC deficiency, died at 8 months of age from cardiac arrest after complications secondary to his diagnosis. Despite her family history, manifestation of symptoms of heterozygous (partial) OTC deficiency went unrecognized by multiple providers based on misconceptions regarding a female's risk for X-linked disease. Despite barriers related to the family's low socioeconomic status, follow-up care by a multidisciplinary metabolic care team, including moderate protein restriction and nitrogen scavenger therapy, led to positive outcomes for the patient. Her twin sister and mother are also heterozygous for variants in OTC and remain controlled on moderate protein restriction. This case illustrates the importance of genotyping all individuals with genetic risk factors for OTC deficiency and the variability in disease manifestation that necessitates tailored treatment approaches for individuals with partial OTC deficiency.
Novel Disease-Associated Missense Single-Nucleotide Polymorphisms Variants Predication by Algorithms Tools and Molecular Dynamics Simulation of Human TCIRG1 Gene Causing Congenital Neutropenia and Osteopetrosis

Khyber Shinwari,Hafiz Muzzammel Rehman,Guojun Liu,Mikhail A. Bolkov,Irina A. Tuzankina,Valery. A. Chereshnev

DOI: https://doi.org/10.3389/fmolb.2022.879875

IF: 6.113

2022-04-29

Frontiers in Molecular Biosciences

Abstract:T Cell Immune Regulator 1, ATPase H + Transporting V0 Subunit A3 (TCIRG1 gene provides instructions for making one part, the a3 subunit, of a large protein complex known as a vacuolar H + -ATPase (V-ATPase). V-ATPases are a group of similar complexes that act as pumps to move positively charged hydrogen atoms (protons) across membranes. Single amino acid changes in highly conserved areas of the TCIRG1 protein have been linked to autosomal recessive osteopetrosis and severe congenital neutropenia. We used multiple computational approaches to classify disease-prone single nucleotide polymorphisms (SNPs) in TCIRG1. We used molecular dynamics analysis to identify the deleterious nsSNPs, build mutant protein structures, and assess the impact of mutation. Our results show that fifteen nsSNPs (rs199902030, rs200149541, rs372499913, rs267605221, rs374941368, rs375717418, rs80008675, rs149792489, rs116675104, rs121908250, rs121908251, rs121908251, rs149792489 and rs116675104) variants are likely to be highly deleterious mutations as by incorporating them into wild protein they destabilize the wild protein structure and function. They are also located in the V-ATPase I domain, which may destabilize the structure and impair TCIRG1 protein activation, as well as reduce its ATPase effectiveness. These mutants have not yet been identified in patients suffering from CN and osteopetrosis while (G405R, R444L, and D517N) reported in our study are already associated with osteopetrosis. Mutation V52L reported in our study was identified in a patient suspected for CN. Finally, these mutants can help to further understand the broad pool of illness susceptibilities associated with TCIRG1 catalytic kinase domain activation and aid in the development of an effective treatment for associated diseases.

biochemistry & molecular biology
Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency

Sitao Li,Yao Cai,Congcong Shi,Mengxian Liu,Bingqing Liu,Lin Lin,Xin Xiao,Hu Hao

DOI: https://doi.org/10.12659/MSM.911295

2018-10-18

Abstract:BACKGROUND The aim of this study was to perform gene detection in 2 clinical cases of highly suspected ornithine transcarbamylase deficiency (OTCD) pediatric patients by first-generation sequencing technology in order to confirm the pathogenic genetic factors of their families and allow the families to undergo genetic counselling and prenatal diagnosis. MATERIAL AND METHODS The peripheral DNA samples of 2 children with highly suspected OTCD (the probands) and their parents were collected. DNA fragments corresponding to exons 1-10 of the OTC gene from the samples were amplified using polymerase chain reaction (PCR), and then subjected to Sanger sequencing to confirm the pathogenic mutation sites. RESULTS The probands were both confirmed to have OTCD. The proband in Family 1 was a male carrying a c.867+1G>C mutation at a splice site within the OTC gene. The gene detection results of amniotic fluid cells at 16 weeks of pregnancy showed that the fetus was a male who also carried the c.867+1G>C mutation. The proband in Family 2 was a male carrying a c.782T>C(p. I261T) mutation in the OTC gene. The gene detection results of amniotic fluid cells at 18 weeks showed that the fetus was a male without pathogenic mutations in the OTC gene. The gene detection results of peripheral blood from the fetus after birth were consistent with those obtained from amniotic fluid cells. CONCLUSIONS Pediatric children who are clinically suspected of OTCD can receive a definitive diagnosis through OTC gene detection.
Benefits of tailored disease management in improving tremor, white matter hyperintensities, and liver enzymes in a child with heterozygous X-linked ornithine transcarbamylase deficiency

Ashley Andrews,Sarah Roberts,Lorenzo D Botto

DOI: https://doi.org/10.1016/j.ymgmr.2022.100891

2022-07-02

Abstract:We report the case of a 19-month-old girl with late-onset ornithine transcarbamylase (OTC) deficiency initially referred to gastroenterology for intermittent vomiting lasting a year and abnormal liver enzymes (AST 730 U/L [reference range 26-55 U/L]; ALT 1213 U/L [reference range 11-30 U/L]) without hepatomegaly. While the patient was hospitalized for liver biopsy, intermittent tremors of the upper extremities with varying severity were noted. The patient was presumed to have hyperammonemia secondary to acute liver failure and was discharged after 5 days; follow-up monitoring led to readmission 7 days later. A brain MRI showed nonspecific bilateral pericallosal and bifrontal white matter FLAIR hyperintensities. These findings raised suspicion for a metabolic disease and prompted a genetics consultation. After inconclusive biochemical testing and worsening clinical status, rapid whole genome sequencing results were obtained identifying a novel, de novo, likely pathogenic, variant c.608C > T (p.Ser203Phe) in the OTC gene. The patient was promptly started on an oral nitrogen scavenger, citrulline supplementation, and protein restriction. Ammonia and glutamine levels normalized within 1 month of treatment and have stayed within the goal ranges with continued tailoring of treatment. Her parents noted resolution of vomiting and improved mood stability. Liver enzymes normalized after 2 months of treatment. The tremor, identified as asterixis, improved and a repeat brain MRI 3 months after the initial imaging showed near-complete resolution of previous white matter hyperintensities.
The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomics

Sook Wah Yee,Christian Macdonald,Darko Mitrovic,Xujia Zhou,Megan L. Koleske,Jia Yang,Dina Buitrago Silva,Patrick Rockefeller Grimes,Donovan Trinidad,Swati S. More,Linda Kachuri,John S. Witte,Lucie Delemotte,Kathleen M. Giacomini,Willow Coyote-Maestas

DOI: https://doi.org/10.1101/2023.06.06.543963

2023-06-07

Abstract:Abstract Membrane transporters play a fundamental role in the tissue distribution of endogenous compounds and xenobiotics and are major determinants of efficacy and side effects profiles. Polymorphisms within these drug transporters result in inter-individual variation in drug response, with some patients not responding to the recommended dosage of drug whereas others experience catastrophic side effects. For example, variants within the major hepatic Human organic cation transporter OCT1 (SLC22A1) can change endogenous organic cations and many prescription drug levels. To understand how variants mechanistically impact drug uptake, we systematically study how all known and possible single missense and single amino acid deletion variants impact expression and substrate uptake of OCT1. We find that human variants primarily disrupt function via folding rather than substrate uptake. Our study revealed that the major determinants of folding reside in the first 300 amino acids, including the first 6 transmembrane domains and the extracellular domain (ECD) with a stabilizing and highly conserved stabilizing helical motif making key interactions between the ECD and transmembrane domains. Using the functional data combined with computational approaches, we determine and validate a structure-function model of OCT1s conformational ensemble without experimental structures. Using this model and molecular dynamic simulations of key mutants, we determine biophysical mechanisms for how specific human variants alter transport phenotypes. We identify differences in frequencies of reduced function alleles across populations with East Asians vs European populations having the lowest and highest frequency of reduced function variants, respectively. Mining human population databases reveals that reduced function alleles of OCT1 identified in this study associate significantly with high LDL cholesterol levels. Our general approach broadly applied could transform the landscape of precision medicine by producing a mechanistic basis for understanding the effects of human mutations on disease and drug response.
Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Hongyan Diao,Peng Zhu,Yong Dai,Wenbiao Chen

DOI: https://doi.org/10.1097/md.0000000000013117

IF: 1.6

2018-01-01

Medicine

Abstract:The multisystemic clinical characteristics of growth retardation, intellectual disability, joint contracture, and hepatopathy in humans are rare and there are no clear diagnoses of these conditions. However, previous studies using exome sequencing have suggested that they are caused by gene mutations, and some related pathogenic gene variants have been found. Here, we performed resequencing and genome-wide variation analysis of 3 individuals (an affected proband and unaffected parents) from a consanguineous family using Solexa sequencing technology to identify mutated genes. The following genetic features were identified: 3,586,775 single-nucleotide polymorphisms (SNPs), 583,416 insertion/deletion polymorphisms (InDels), and 8579 structural variations (SVs) in the genome of the father; 3,624,800 SNPs, 608,685 InDels, and 8,827 SVs in the genome of the mother; 3,574,431 SNPs, 571,196 InDels, and 8371 SVs in the genome of the proband. Variations between samples were determined by comparative analysis of authentic collections of SNPs and were functionally annotated. Variations in several important genes, including SEC22B, FLG, ZNF717, MUC4, TRIL, CTAGE4, FOXG1, LOC100287399, KRTAP1-3, and LRRC37A3, were surveyed by alignment analysis. The results present new evidence that mutations in 11 genes may be associated with characteristic clinical growth retardation, intellectual disability, joint contracture, and hepatopathy.
Interferon induction in New Zealand black mice by murine leukemia virus.

B. Siegel,M. Brown,J. Morton

DOI: https://doi.org/10.4049/jimmunol.111.2.644

1973-08-01

Abstract: Rauscher leukemia virus (RLV)2 has been reported to induce little or no interferon in a number of murine systems, such as BALB/c (1) and NMRL (2) strains. In the case of the random-bred CD-1 strain, Glasgow and Friedman (1) observed relatively high serum levels of interferon in adult RLV-infected mice with accompanying resistance to the disease. We have extended these studies to an investigation of the interferon response to RLV in the autoimmune New Zealand Black (NZB) model and for comparative purposes have included the C57BL/6 and BALB/c strains. The female NZB mice employed represented the seventh and eighth generations in this laboratory from breeding stock (generations 57 and 58) obtained from the Otago University Medical School, Dunedin, New Zealand, and have since been maintained in a closed colony. These NZB mice are vigorous, healthy, and relatively long-lived with 50% survival at 17 months; their microbiologic status has not been assessed.
Lysine 88 Acetylation Negatively Regulates Ornithine Carbamoyltransferase Activity in Response to Nutrient Signals.

Wei Yu,Yan Lin,Jun Yao,Wei Huang,Qunying Lei,Yue Xiong,Shimin Zhao,Kun-Liang Guan

DOI: https://doi.org/10.1074/jbc.m901921200

2009-01-01

Abstract:Ornithine carbamoyltransferase (OTC) is a key enzyme in the urea cycle to detoxify ammonium produced from amino acid catabolism. OTC deficiency is an X-linked genetic disorder ranging from fatal in newborns to hyperammonemia and anorexia in adults. Through affinity purification of acetylated peptides and mass spectrometry, we identified that OTC is acetylated on lysine residues, including Lys88, which is also mutated in OTC-deficient patients. OTC acetylation was confirmed to occur under physiological conditions. Biochemical characterizations revealed that OTC Lys88 acetylation decreases the affinity for carbamoyl phosphate, one of the two OTC substrates, and the maximum velocity, whereas the K(m) for ornithine, the other OTC substrate, is not affected. Furthermore, Lys88 acetylation is regulated by both extracellular glucose and amino acid availability, indicating that OTC activity may be regulated by cellular metabolic status. Our results provide an example of the novel mechanism of regulating metabolic enzyme activity through protein acetylation.
Massively parallel variant characterization identifies <i>NUDT15</i> alleles associated with thiopurine toxicity

K. L. de Wit,B. E. White,D. Goldsmith

DOI: https://doi.org/10.1073/pnas.1915680117

2020-01-01

Abstract:As a prototype of genomics-guided precision medicine, individualized thiopurine dosing based on pharmacogenetics is a highly effective way to mitigate hematopoietic toxicity of this class of drugs. Recently, NUDT15 deficiency was identified as a genetic cause of thiopurine toxicity, and NUDT15-informed preemptive dose reduction was quickly adopted in clinical settings. To exhaustively identify pharmacogenetic variants in this gene, we developed massively parallel NUDT15 function assays to determine the variants' effect on protein abundance and thiopurine cytotoxicity. Of the 3,097 possible missense variants, we characterized the abundance of 2,922 variants and found 54 hotspot residues at which variants resulted in complete loss of protein stability. Analyzing 2,935 variants in the thiopurine cytotoxicity-based assay, we identified 17 additional residues where variants altered NUDT15 activity without affecting protein stability. We identified structural elements key to NUDT15 stability and/or catalytical activity with single amino acid resolution. Functional effects for NUDT15 variants accurately predicted toxicity risk alleles in patients treated with thiopurines with far superior sensitivity and specificity compared to bioinformatic prediction algorithms. In conclusion, our massively parallel variant function assays identified 1,152 deleterious NUDT15 variants, providing a comprehensive reference of variant function and vastly improving the ability to implement pharmacogenetics-guided thiopurine treatment individualization.
Analysis of clinical features, biochemical analysis and gene mutations in one Chinese pedigree with neonatal-onset ornithine transcarbamylase deficiency

Wei-hua SUN,Yi YANG,Yue-ping ZHANG,Xiao-tian LI,Min ZHANG,Yun CAO,Yi WANG

DOI: https://doi.org/10.3760/cma.j.issn.0578-1310.2011.05.009

2011-01-01

Abstract:Objective This study aimed at understanding clinical features, biochemistry and gene mutation in one Chinese pedigree which had a neonatal-onset ornithine transcarbamylase deficiency ( OTCD )boy, and exploring the significance of ornithine transcarbamylase analysis in prenatal diagnosis.Method The clinical and biochemical data of one case were analyzed.The amino acids in blood and organic acids in urine were analyzed by mass spectrum technology.The OTC gene mutation was detected using polymerase chain reaction (PCR) and DNA direct sequencing for the case, his parents and the fetus amniocyte and her blood after birth.Result The age of onset was 3 days after birth, he began to have poor reaction, difficulty to feed, high blood ammonia, infection, slight metabolic acidosis, which were consistent with the clinical diagnosis of urea cycle disorders.The boy died at the age of 9 days.Citrulline of blood was detected twice,and were 0.86 μm and 1.06 μm, respectively.The orotic acid was elevated ( 124 μm/M Creatinine), and urine lactic acid was significantly elevated.The citrulline and orotic acid in his parents and their second baby were normal in DBS and urine.One nonsense mutation in the OTC gene was found at the exon 9 ( C.958 C ＞ T) and his mother was the heterozygote, which caused an arginine to terminate the code at position 320 of the protein (R320X).Two other mutations were also detected at intron 9 ( C.1005 + 132 InsT) and intron 5 (C.542 + 134 G ＞ G/A).But the analysis of his father's DNA, the fetus amniocyte and her bloodwas normal.Conclusion The mutation of C.958 C ＞ T in OTC gene may occur during neonatal period.This mutation would result in a very severe symptom, even die suddenly several days after birth, if it was a boy.It needs more researches to discuss whether the C.1005 + 132 InsT in intron 9 and C.542 + 134 G ＞G/A in intron 5 were associated with the neonatal-onset OTCD.The DNA analysis of OTC gene could be utilized for the prenatal diagnosis.
Mydriasis in giant-cell arteritis.

J. Coppeto,T. Greco

1989-12-01

Abstract:A previously healthy 60-year-old woman developed headache, cervical pain, bilateral mydriasis (right greater than left), and bilateral conjunctival injection as the sole manifestations of acute giant-cell arteritis.
The landscape of regional missense mutational intolerance quantified from 125,748 exomes

Katherine R. Chao,Lily Wang,Ruchit Panchal,Calwing Liao,Haneen Abderrazzaq,Robert Ye,Patrick Schultz,John Compitello,Riley H. Grant,Jack A. Kosmicki,Ben Weisburd,William Phu,Michael W. Wilson,Kristen M. Laricchia,Julia K. Goodrich,Daniel Goldstein,Jacqueline I. Goldstein,Christopher Vittal,Timothy Poterba,Samantha Baxter,Nicholas A. Watts,Matthew Solomonson,gnomAD Consortium,Grace Tiao,Heidi L. Rehm,Benjamin M. Neale,Michael E. Talkowski,Daniel G. MacArthur,Anne O’Donnell-Luria,Konrad J. Karczewski,Predrag Radivojac,Mark J. Daly,Kaitlin E. Samocha

DOI: https://doi.org/10.1101/2024.04.11.588920

2024-05-03

Abstract:Missense variants can have a range of functional impacts depending on factors such as the specific amino acid substitution and location within the gene. To interpret their deleteriousness, studies have sought to identify regions within genes that are specifically intolerant of missense variation . Here, we leverage the patterns of rare missense variation in 125,748 individuals in the Genome Aggregation Database (gnomAD) against a null mutational model to identify transcripts that display regional differences in missense constraint. Missense-depleted regions are enriched for ClinVar pathogenic variants, missense variants from individuals with neurodevelopmental disorders (NDDs) , and complex trait heritability. Following ClinGen calibration recommendations for the ACMG/AMP guidelines, we establish that regions with less than 20% of their expected missense variation achieve moderate support for pathogenicity. We create a missense deleteriousness metric (MPC) that incorporates regional constraint and outperforms other deleteriousness scores at stratifying case and control missense variation, with a strong enrichment in NDDs. These results provide additional tools to aid in missense variant interpretation.

Genomics
Functional characterization of all missense variants and comparison to in silico models of pathogenicity

Hirokazu Kimura,Kamel Lahouel,Cristian Tomasetti,Nicholas J. Roberts

DOI: https://doi.org/10.1101/2023.12.28.573507

2024-09-22

Abstract:Interpretation of variants identified during genetic testing is a significant clinical challenge. In this study, we developed a high-throughput CDKN2A functional assay and characterized all possible missense variants. We found that 17.7% of all missense variants were functionally deleterious. We also used our functional classifications to assess the performance of in silico models that predict the effect of variants, including recently reported models based on machine learning. Notably, we found that all in silico models performed similarly when compared to our functional classifications with accuracies of 39.5-85.4%. Furthermore, while we found that functionally deleterious variants were enriched within ankyrin repeats, we did not identify any residues where all missense variants were functionally deleterious. Our functional classifications are a resource to aid the interpretation of variants and have important implications for the application of variant interpretation guidelines, particularly the use of in silico models for clinical variant interpretation.

Genetics
[Rational lymphadenectomy in patients with cervical nodes metastasis for carcinoma of the lower third esophagus].

M. Baba,Y. Heiji,M. Shimada,S. Nakano,S. Natsugoe,T. Aikou

1997-09-01

Abstract:Prognostic value of removing cervical nodes in patients with carcinoma of the lower third esophagus is extremely controversial. Of 93 patients with curative esophagectomy via trans-thoracic approach, cervical nodes were involved in five patients (13%), upper mediastinal nodes in 12 patients (30%), and para-aortic nodes in only one patients (3%) for 40 patients whose proximal part of the tumor invading the mid-esophagus from below. Of the remaining 53 patients with tumor extent confined to the lower third esophagus, cervical nodes were involved in only one patients (2%), upper mediastinal nodes in five patients (9%), and paraaortic nodes in six patients (11%). Three of the five patients with cervical metastasis whose proximal part of the tumor invading the mid-esophagus survived for at least 22 months or more following three-field lymphadenectomy. Removing the cervical nodes in patients with carcinoma of the lower third esophagus may have some role to improve the survival if the tumor invades the mid-esophagus from below.

THE ARGENTINE CITIZENS DECLARATION.

Selective upregulation of a functional β7 integrin on differentiating eosinophils

[Hypertrophy of the ileocecal valve. Malabsorption syndrome].

Newborn Screening for Ornithine Transcarbamylase Deficiency in Zhejiang Province and the Follow-Up Analysis

Variant analysis and PGT-M of OTC gene in a Chinese family with ornithine carbamoyltransferase deficiency

Tubular epithelial reflux in the kidney in aflatoxin poisoning.

A yeast-based complementation assay elucidates the functional impact of 200 missense variants in human PSAT1

Variable disease manifestations and metabolic management within a single family affected by ornithine transcarbamylase deficiency

Novel Disease-Associated Missense Single-Nucleotide Polymorphisms Variants Predication by Algorithms Tools and Molecular Dynamics Simulation of Human TCIRG1 Gene Causing Congenital Neutropenia and Osteopetrosis

Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency

Benefits of tailored disease management in improving tremor, white matter hyperintensities, and liver enzymes in a child with heterozygous X-linked ornithine transcarbamylase deficiency

The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomics

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Interferon induction in New Zealand black mice by murine leukemia virus.

Lysine 88 Acetylation Negatively Regulates Ornithine Carbamoyltransferase Activity in Response to Nutrient Signals.

Massively parallel variant characterization identifies <i>NUDT15</i> alleles associated with thiopurine toxicity

Analysis of clinical features, biochemical analysis and gene mutations in one Chinese pedigree with neonatal-onset ornithine transcarbamylase deficiency

Mydriasis in giant-cell arteritis.

The landscape of regional missense mutational intolerance quantified from 125,748 exomes

Functional characterization of all missense variants and comparison to in silico models of pathogenicity

[Rational lymphadenectomy in patients with cervical nodes metastasis for carcinoma of the lower third esophagus].